Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant

Visit http://www.ecancer.org for more.

Dr Bernardo Rapoport (The Medical Oncology Centre, Johannesburg, South Africa) speaks to ecancertv at ESMO2014 about the results of his phase III trial, examining the use of rolapitant for the prevention of chemotherapy-induced nausea and vomiting.

ecancer's filming at ESMO has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

• categoría